Effects of supraspinal orphanin FQ/nociceptin

Peptides

Volumn 21, Issue 7, 2000, Pages 1037-1045

  Grisel, Judith E ^a   Mogil, Jeffrey S ^b  

^a FURMAN UNIVERSITY   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIGAND; MORPHINE; NOCICEPTIN; NOCICEPTIN RECEPTOR; NOCICEPTIN RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG;

ANALGESIA; ANIMAL EXPERIMENT; BEHAVIOR; BRAIN; GENOTYPE; HYPERALGESIA; METHODOLOGY; MOUSE; NOCICEPTION; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT; REVIEW; STRESS;

EID: 0033812102     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(00)00236-9     Document Type: Article

References (95)

1. Bryant W., Janik J., Baumann M., Callahan P. Orphanin FQ stimulates prolactin and growth hormone release in male and female rats. Brain Res. 807:1998;228-233.
2. 2 is an agonist of the nociceptin (ORL1) receptor. Eur J Pharmacol. 349:1998;R5-R6.
3. Calo' G., Rizzi A., Marzola G., et al. Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay. Br J Pharmacol. 125:1998;373-378.
4. 2, a peripheral ORL-1 receptor antagonist, acts as an agonist in the rat spinal cord. Br J Pharmacol. 125:1998;949-951.
5. Chen Z., Inoue M., Hopkins E., et al. Nociceptin/OFQ gene knockout reveals an antinociceptive role for the nociceptin/OFQ in the mouse. Soc Neurosci Abstr. 25:1999;1472.
6. Ciccocioppo R., Panocka I., Polidori C., Regoli D., Massi M. Effect of nociceptin on alcohol intake in alcohol-preferring rats. Psychopharmacology (Berl). 141:1999;220-224.
7. Connor M., Vaughan C.W., Chieng B., Christie M.J. Nociceptin receptor coupling to a potassium conductance in rat locus coeruleus neurones in vitro. Br J Pharmacol. 119:1996;1614-1618.
8. d'Amore A., Chiarotti F., Renzi P. High-intensity nociceptive stimuli minimize behavioral effects induced by restraining stress during the tail-flick test. J Pharmacol Toxicol Meth. 27:1992;197-201.
9. Devine D.P., Reinscheid R.K., Monsma F.J. Jr, Civelli O., Akil H. The novel neuropeptide orphanin FQ fails to produce conditioned place preference or aversion. Brain Res. 727:1996;225-229.
10. Devine D.P., Taylor L., Reinscheid R.K., Monsma F.J. Jr, Civelli O., Akil H. Rats rapidly develop tolerance to the locomotor-inhibiting effects of the novel neuropeptide orphanin FQ. Neurochem Res. 21:1996;1387-1396.
11. Du L.N., Wu G.C., Cao X.D. Modulation of orphanin FQ or electroacupuncture (EA) on immune function of traumatic rats. Acupunct Electrother Res. 23:1998;1-8.
12. Fields H.L., Heinricher M.M. Brainstem modulation of nociceptor-driven withdrawal reflexes. Ann NY Acad Sci. 563:1989;34-44.
13. Gintzler A.R., Adapa I.D., Toll L., Medina V.M., Wang L. Modulation of enkephalin release by nociceptin (orphanin FQ). Eur J Pharmacol. 325:1997;29-34.
14. 2 acts as an agonist of the orphanin FQ/nociceptin receptor in vivo. Eur J Pharmacol. 357:1998;1-3.
15. Grisel J.E., Mogil J.S., Belknap J.K., Grandy D.K. Orphanin FQ acts as a supraspinal, but not a spinal, anti-opioid peptide. Neuroreport. 7:1996;2125-2129.
16. Grisel J.E., Mogil J.S., Grahame N.J., et al. Ethanol oral self-administration is increased in mutant mice with decreased β-endorphin expression. Brain Res. 835:1999;62-67.
17. Guerrini R., Calo' G., Rizzi A., Bigoni R., Bianchi C., Salvadori S., Regoli D. A new selective antagonist of the nociceptin receptor. Br J Pharmacol. 123:1998;163-165.
18. Heinricher M.M., McGaraughty S., Grandy D.K. Circuitry underlying antiopioid actions of orphanin FQ in the rostral ventromedial medulla. J Neurophysiol. 78:1997;3351-3358.
19. Henderson G., McKnight A.T. The orphan opioid receptor and its endogenous ligand - nociceptin/orphanin FQ. Trends Pharmacol Sci. 18:1997;293-300.
20. Hiramatsu M., Inoue K. Effects of nocistatin on nociceptin-induced impairment of learning and memory in mice. Eur J Pharmacol. 367:1999;151-155.
21. Jenck F., Moreau J.-L., Martin J.R., et al. Orphanin FQ acts as an anxiolytic to attenuate behavioral responses to stress. Proc Natl Acad Sci USA. 94:1997;14854-14858.
22. 2 and orphanin FQ/nociceptin (OFQ/N) produce similar cardiovascular and renal responses in conscious rats. J Pharmacol Exp Ther. 289:1999;173-180.
23. Kapusta D.R., Sezen S.F., Chang J.-K., Lippton H., Kenigs V.A. Diuretic and antinatriuretic responses produced by the endogenous opioid-like peptide, nociceptin (orphanin FQ). Life Sci. 60:1997;PL15-PL21.
24. Kavaliers M., Choleris E., Saucier D.M. The NMDA receptor antagonist, NPC 12626, reduces the pronociceptive effects of orphanin FQ and kappa opiate antinociception in the land snail, Cepaea nemoralis. Peptides. 18:1997;943-947.
25. Kavaliers M., Perrot-Sinal T.S. Pronociceptive effects of the neuropeptide, nociceptin, in the land snail, Cepaea nemoralis. Peptides. 17:1996;763-768.
26. Kelly D. De. Stress-induced analgesia. Ann N Y Acad Sci. 467:1986.
27. King M., Chang A., Pasternak G.W. Functional blockade of opioid analgesia by orphanin FQ/nociceptin. Biochem Pharmacol. 55:1998;1537-1540.
28. Kolesnikov Y.A., Pasternak G.W. Peripheral orphanin FQ/nociceptin analgesia in the mouse. Life Sci. 64:1999;2021-2028.
29. Koster A., Montkowski A., Schulz S., et al. Targeted disruption of the orphanin FQ/nociceptin gene increases stress susceptibility and impairs stress adaptation in mice. Proc Natl Acad Sci USA. 96:1999;10444-10449.
30. Lee K., Nicholson J.R., McKnight A.T. Nociceptin hyperpolarises neurones in the rat ventromedia hypothalamus. Neurosci Lett. 239:1997;37-40.
31. Lutfy K., Sharza S.A., Maidment N.T. Tolerance develops to the inhibitory effect of orphanin FQ on morphine-induced antinociception in the rat. Neuroreport. 10:1999;103-106.
32. + currents in hippocampal CA1 neurons by both ORL-1 and opiate receptor mechanisms. J Neurophysiol. 82:1999;1776-1785.
33. Mamiya T., Noda Y., Nishi M., Takeshima H., Nabeshima T. Enhancement of spatial attention in nociceptin/orphanin FQ receptor-knockout mice. Brain Res. 783:1998;236-240.
34. Manabe T., Noda Y., Mamiya T., et al. Facilitation of long-term potentiation and memory in mice lacking nociceptin receptors. Nature. 394:1998;577-581.
35. Martin W.J., Malmberg A.B., Basbaum A.I. Pain nocistatin spells relief . Curr Biol. 8:1998;R525-R527.
36. Mathis J.P., Goldberg I.E., Rossi G.C., Leventhal L., Pasternak G.W. Antinociceptive analogs of orphanin FQ/nociceptin(1-11). Life Sci. 63:1998;PL161-PL166.
37. Meis S., Pape H.C. Postsynaptic mechanisms underlying responsiveness of amygdaloid neurons to nociceptin/orphanin FQ. J Neurosci. 18:1998;8133-8144.
38. 1 receptor. Nature. 377:1995;532-535.
39. Minami T., Okuda-Ashitaka E., Nishiuchi Y., Kimura T., Tachibana S., Mori H., Ito S. Anti-nociceptive responses produced by human putative counterpart of nocistatin. Br J Pharmacol. 124:1998;1016-1018.
40. Mogil J.S. The genetic mediation of individual differences in sensitivity to pain and its inhibition. Proc Natl Acad Sci USA. 96:1999;7744-7751.
41. Mogil J.S., Grisel J.E. Transgenic studies of pain. Pain. 77:1998;107-128.
42. Mogil J.S., Grisel J.E., Reinscheid R.K., Civelli O., Belknap J.K., Grandy D.K. Orphanin FQ is a functional anti-opioid peptide. Neuroscience. 75:1996;333-337.
43. Mogil J.S., Grisel J.E., Zhang G., Belknap J.K., Grandy D.K. Functional antagonism of μ-, δ- and κ-opioid antinociception by orphanin FQ. Neurosci Lett. 214:1996;131-134.
44. Mogil J.S., Nessim L.A., Wilson S.G. Strain-dependent effects of supraspinal orphanin FQ/nociceptin on thermal nociceptive sensitivity in mice. Neurosci Lett. 261:1999;147-150.
45. Morgan M.M., Grisel J.E., Robbins C.S., Grandy D.K. Antinociception mediated by the periaqueductal gray is attenuated by orphanin FQ. Neuroreport. 8:1997;3431-3434.
46. Murphy N.P., Ly H.T., Maidment N.T. Intracerebroventricular orphanin FQ/nociceptin suppresses dopamine release in the nucleus accumbens of anaesthetized rats. Neuroscience. 75:1996;1-4.
47. + evoked glutamate release from rat cerebrocortical slices. Br J Pharmacol. 119:1996;1081-1083.
48. Nishi M., Houtani T., Noda Y., et al. Unrestrained nociceptive response and disregulation of hearing ability in mice lacking the nociceptin/orphanin FQ receptor. EMBO J. 16:1997;1858-1864.
49. Noda Y., Mamiya T., Nabeshima T., Nishi M., Higashioka M., Takeshima H. Loss of antinociception induced by naloxone benzoylhydrazone in nociceptin receptor-knockout mice. J Biol Chem. 273:1998;18047-18051.
50. Okuda-Ashitaka E., Minami T., Tachibana S., et al. Nocistatin, a peptide that blocks nociceptin action in pain transmission. Nature. 392:1998;286-289.
51. Osinski M.A., Bass P., Gaumnitz E.A. Peripheral and central actions of orphanin FQ (nociceptin) on murine colon. Am J Physiol. 276:1999;G125-G131.
52. 3-related opioid receptor. Mol Pharmacol. 47:1995;1180-1188.
53. Pasternak G.W., Standifer K.M. Reply to M. Wollemann. Trends Pharmacol Sci. 17:1996;217-218.
54. Paul D., Levison J.A., Howard D.H., Pick C.G., Hahn E.F., Pasternak G.W. Naloxone benzoylhydrazone (NalBzoH) analgesia. J Pharmacol Exp Ther. 255:1990;769-774.
55. Pick C.G., Cheng J., Paul D., Pasternak G.W. Genetic influences in opioid analgesic sensitivity in mice. Brain Res. 566:1991;295-298.
56. Pomonis J.D., Billington C.J., Levine A.S. Orphanin FQ, agonist of orphan opioid receptor ORL1, stimulates feeding in rats. Neuroreport. 8:1996;369-371.
57. 3H]naloxone benzoylhydrazone a reversible κ and slowly dissociable μ opiate . Mol Pharmacol. 35:1988;67-74.
58. Rady J.J., Roerig S.C., Fujimoto J.M. Heroin acts on different opioid receptors than morphine in Swiss Webster and ICR mice to produce antinociception. J Pharmacol Exp Ther. 256:1991;448-457.
59. Reinscheid R.K., Nothacker H.-P., Bourson A., et al. Orphanin FQ a novel neuropeptide which is a natural ligand of an opioid-like G protein-coupled receptor . Science. 270:1995;792-794.
60. Rossi G.C., Leventhal L., Bolan E.A., Pasternak G.W. Pharmacological characterization of orphanin FQ/nociceptin and its fragments. J Pharmacol Exp Ther. 282:1997;858-865.
61. Rossi G.C., Leventhal L., Pasternak G.W. Naloxone sensitive orphanin FQ-induced analgesia in mice. Eur J Pharmacol. 311:1996;R7-R8.
62. 141-157, in mice. Neuroreport. 9:1998;1165-1168.
63. Rossi G.C., Perlmutter M., Leventhal L., Talatti A., Pasternak G.W. Orphanin FQ/nociceptin analgesia in the rat. Brain Res. 792:1998;327-330.
64. Sandin J., Georgieva J., Schott P.A., Ogren S.O., Terenius L. Nociceptin/orphanin FQ microinjected into hippocampus impairs spatial learning in rats. Eur J Neurosci. 9:1997;194-197.
65. Schulz S., Schreff M., Nub D., Gramsch C., Hollt V. Nociceptin/orphanin FQ, and opioid peptides show overlapping distribution but not co-localization in pain-modulatory regions. Neuroreport. 7:1996;3021-3025.
66. Shimohigashi Y., Hatano R., Fujita T., et al. Sensitivity of opioid receptor-like receptor ORL1 for chemical modification on nociceptin, a naturally occurring nociceptive peptide. J Biol Chem. 271:1996;23642-23645.
67. Stratford T.R., Holahan M.R., Kelley A.E. Injections of nociceptin into the nucleus accumbens shell or ventromedial hypothalamic nucleus increase food intake. Neuroreport. 8:1957;423-426.
68. Suaudeau C., Florin S., Meunier J.-C., Costentin J. Nociceptin-induced apparent hyperalgesia in mice as a result of the prevention of opioid autoanalgesic mechanisms triggered by the stress of an intracerebroventricular injection. Fundam Clin Pharmacol. 12:1998;420-425.
69. Sulaiman M.R., Niklasson M., Tham R., Dutia M.B. Modulation of vestibular function by nociceptin/orphanin FQ an in vivo and in vitro study . Brain Res. 828:1999;74-82.
70. Taylor F., Dickenson A. Nociceptin/orphanin FQ. A new opioid, a new analgesic? Neuroreport. 9:1998;R65-R70.
71. Tian J.-H., Xu W., Fang Y., Grisel J.E., Mogil J.S., Grandy D.K., Han J.-S. Involvement of endogenous orphanin FQ in electroacupuncture-induced analgesia. Neuroreport. 8:1997;497-500.
72. Tian J.-H., Xu W., Fang Y., Mogil J.S., Grisel J.E., Grandy D.K., Han J.-S. Bidirectional modulatory effect of orphanin FQ on morphine-induced analgesia antagonism in brain and potentiation in spinal cord of rat . Br J Pharmacol. 120:1997;676-680.
73. Tian J.-H., Zhang W., Fang Y., Xu W., Grandy D.K., Han J.-S. Endogenous orphanin FQ evidence for a role in the modulation of electroacupuncture analgesia and the development of tolerance to analgesia produced by morphine and electroacupuncture . Br J Pharmacol. 124:1998;21-26.
74. Ueda H., Yamaguchi T., Tokuyama S., Inoue M., Nishi M., Takeshima H. Partial loss of tolerance liability to morphine analgesia in mice lacking the nociceptin receptor gene. Neurosci Lett. 237:1997;136-138.
75. Vanderah T.W., Raffa R.B., Lashbrook J., Burritt A., Hruby V., Porreca F. Orphanin-FQ/nociceptin lack of antinociceptive, hyperalgesic or allodynic effects in acute thermal or mechanical tests following intracerebroventricular or intrathecal administration to mice or rats . Eur J Pain. 2:1998;267-280.
76. Vaughan C.W., Christie M.J. Increase by the ORL(1) receptor (opioid receptor-like 1) ligand, nociceptin, of inwardly rectifying K conductance in dorsal raphe nucleus neurones. Br J Pharmacol. 117:1996;1609-1611.
77. 1 receptor ligand nociceptin on membrane properties of rat periaqueductal gray neurons in vitro. J Neurosci. 17:1997;996-1003.
78. + conductance. Neuroendocrinology. 67:1998;73-82.
79. Walker J.R., Spina M., Terenius L., Koob G.F. Nociceptin fails to affect heroin self-administration in the rat. Neuroreport. 9:1998;2243-2247.
80. Wang J.-L., Zhu C.-B., Cao X.-D., Wu G.-C. Distinct effect of intracerebroventricular and intrathecal injections of nociceptin/orphanin FQ in the rat formalin test. Regul Pept. 79:1999;159-163.
81. Wang X.-M., Zhang K.M., Mokha S.S. Nociceptin (orphanin FQ), an endogenous ligand for the QRL1 (opioid-receptor-like1) receptor; modulates responses of trigeminal neurons evoked by excitatory amino acids and somatosensory stimuli. J Neurophysiol. 76:1996;3568-3572.
82. Wang Y.Q., Zhu C.B., Wu G.C., Cao X.D., Wang Y., Cui D.F. Effects of orphanin FQ on endomorphin-1 induced analgesia. Brain Res. 835:1999;241-246.
83. 3-opioid receptor? Trends Pharmacol Sci. 17:1996;217.
84. Woolf C.J., Mannion R.J., Neumann S. Null mutations lacking substance elucidating pain mechanisms by genetic pharmacology . Neuron. 20:1998;1063-1066.
85. 2, a proposed antagonist of the nociceptin receptor, is a potent and stable agonist in the rat spinal cord. Neurosci Lett. 249:1998;127-130.
86. Yaksh T.L., Rudy T.A. Narcotic analgesics CNS sites and mechanisms of action as revealed by intracerebral injection techniques . Pain. 4:1978;299-359.
87. Yamamoto T., Nozaki-Taguchi N., Sakashita Y., Kimura S. Nociceptin/orphanin FQ. role in nociceptive information processing. Prog Neurobiol. 57:1999;527-535.
88. Yu T.-P., Fein J., Phan T., Evans C.J., Xie C.W. Orphanin FQ inhibits synaptic transmission and long-term potentiation in rat hippocampus. Hippocampus. 7:1997;88-94.
89. Yuan L., Han Z., Chang J.-K., Han J.-S. Accelerated release and production of orphanin FQ in brain of chronic morphine tolerant rats. Brain Res. 826:1999;330-334.
90. Zaki P.A., Evans C.J. ORL-1 an awkward child of the opioid receptor family . Neuroscientist. 4:1998;172-184.
91. Zhao C.-S., Li B.-S., Zhao G.-Y., et al. Nocistatin reverses the effect of orphanin FQ/nociceptin in antagonizing morphine analgesia. Neuroreport. 10:1999;297-299.
92. Zhu C.-B., Cao X.-D., Xu S.-F., Wu G.-C. Orphanin FQ potentiates formalin-induced pain behavior and antagonizes morphine analgesia in rats. Neurosci Lett. 235:1997;37-40.
93. Zhu C-B, Xu S.-F., Cao X-D, Wu G.-C. Antagonistic action of orphanin FQ on acupuncture analgesia in rat brain. Acupunct Electrother Res, Int J 1996;21:199-205.
94. Bigoni R., Calo' G., Rizzi A., Guerrini R., De Risi C., Hashimoto Y., Hashiba E., Lambert D.G., Regoli D. In vitro characterization of J-113397, a non-peptide nociceptin/orphanin FQ receptor antagonist Naunyn Schmiedebergs. Arch Pharmacol. 361:2000;565-568.
95. Ozaki S., Kawamoto H., Itoh Y., Miyaji M., Iwasawa Y., Ohta H. A potent and highly selective nonpeptidyl nociceptin/orphanin FQ receptor (ORL1) antagonist J-113397 . Eur J Pharmacol. 387:2000;R17-R18.